This compound is an orexin antagonist active pharmaceutical ingredient, characterized as a substituted diazepane with a triazole-substituted phenyl group. It functions as a pharmaceutical raw material for research and manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Suvorexant
pharmaceutical raw material
Suvorexant metabolite M9
pharmaceutical raw material
5-chloro-2-[(5S)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole
pharmaceutical raw material
(R)-(-)-1-Aminoindane hydrochloride
pharmaceutical raw material
[(7R)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
FURCQDWTOXYTNN-CYBMUJFWSA-N
C[C@@H]1CCNCCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.